Advertise on podcast: Blind Spot - The Eye Doctor's Podcast

In this episode Zale speaks with Dr. Jacob Rullo, a clinician and researcher focused on dry eye disease and meibomian gland dysfunction. Dry eye is often treated as a simple lubrication problem, but our understanding of the disease is changing. Dr. Rullo explains the growing importance of meibomian gland dysfunction and evaporative dry eye, and how the DEWS III framework is changing the way we approach diagnosis and treatment. The conversation focuses on artificial tears — from traditional formulations to newer hyaluronic acid, osmoprotectant and lipid-containing drops — and how clinicians can choose the right tear for the right patient rather than simply reaching for whatever sample is available. They also discuss meibomian gland dysfunction, heat, lid hygiene, IPL and LipiFlow, the limitations of current treatments, and Dr. Rullo's research into restoring meibomian gland function. Finally, they explore how reduced blinking and increasing screen time may be contributing to a growing dry eye problem. Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Zale sits down with pediatric ophthalmologist Dr. Christine Law to unpack when children should get their eyes checked and why that question is more nuanced than it seems. They break down the difference between basic vision screening and a full comprehensive eye exam, including what each can and cannot detect. Dr. Law shares practical guidance on common refractive issues in children like hyperopia, myopia, and astigmatism, and when glasses may be needed. The conversation also covers why early detection matters for preventing amblyopia and how parents can think about eye care as their kids grow. This episode is sponsored by Thea Pharma Canada. Learn more about them at https://theapharma.ca/who-we-are Listen to our previous episode on the Myopia Epidemic with Dr. Rupa Wong at https://www.spreaker.com/episode/9-myopia-epidemic-dr-rupa-wong--56113340 Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Implantable collamer lenses, or ICLs, have evolved from a niche alternative for extreme prescriptions into a mainstream refractive option that is increasingly being chosen over LASIK—even for some ideal LASIK candidates. In this episode, we explore what changed: the history of the procedure, how ICL surgery is performed, the real risks and safety considerations, and how the visual outcomes compare with LASIK. We also dive into higher-order aberrations, stability of refraction, regression, and whether ICLs may offer superior quality of vision in certain patients. Refractive surgery expert Dr. Avi Wallerstein joins the podcast.  Dr. Avi Wallerstein is the co-founder of Vision Group - https://www.thevisiongroup.com/  Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

The use of intracameral antibiotics - specifically intracameral moxifloxacin - has become relatively mainstream practice in cataract surgery. But how effective is it in preventing endophthalmitis? Are ophthalmologists administering it correctly?  And what are some of the potential adverse effects that can result from intracameral moxifloxacin? Leading expert in the field, Dr. Steve Arshinoff, joins the podcast.  This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

When a posterior capsule rupture occurs during cataract surgery, the standard teaching is that we do an anterior vitrectomy if the hyaloid face is broken and vitreous comes forward. But why is the anterior vitrectomy so important? Is it always 100% necessary? And what are some tips on performing the anterior vitrectomy as safely and effectively as possible. Dr. Uday Devgan, aka The Cataract Coach, joins the podcast. Check out The Cataract Coach at https://www.youtube.com/@UdayDevgan This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca/ Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Dr. Elizabeth Yeu shares her expertise on multifocal intraocular lenses (IOLs), discussing patient communication, surgical considerations, optics, and personality traits that influence candidacy. Whether you're an ophthalmologist or optometrist, gain practical tips to improve patient outcomes and satisfaction. This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode of Blind Spot, Zale discusses the controversial topic of bilateral cataract surgery with Dr. Steve Arshinoff, a leading expert in the field. They explore the historical context, current debates, and the potential benefits and risks associated with performing cataract surgery on both eyes simultaneously. Dr. Arshinoff shares insights from his extensive research and experience, addressing common concerns such as infection risks and refractive surprises, and highlights the importance of evidence-based practice in ophthalmology. This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode of Blind Spot, Zale sits down with Dr. Kieran Murphy, a renowned inventor and professor of radiology, to explore the essence of invention and creativity in medicine. Dr. Murphy shares his journey from medical innovations to his thoughts on the socio-economic factors that influence creativity. Discover how invention is not just about genius but a mindset, and learn about the challenges and triumphs in the world of medical creativity.  Dr. Murphy's Book 'The Essence of Invention' https://www.amazon.ca/Essence-Invention-Medicine-Joy-Creativity/dp/1459754034 This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Zale sits down with Dr. Benny Jeng, head of the ZEDS study which investigated the role of longer time antiviral treatmetn for patients with HZO with ocular involvement.  They review the results of the study and disuss whether long term oral antivirals reduces zoster recurrences and the severity and duration of post-herpetic neuralgia.  This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Dr. Matthew Tennant discusses the common issue of floaters in ophthalmology, exploring their physiological basis, patient experiences, and the limitations of current treatment options. The conversation delves into traditional methods like vitrectomy and YAG vitreolysis, highlighting their risks and effectiveness. Dr. Tennant also introduces PulseMedica, a startup developing innovative technology aimed at providing a safer, non-invasive solution for treating floaters, emphasizing the potential of femto laser technology. The episode concludes with reflections on the future of floater treatment and the ongoing challenges faced by both patients and clinicians. This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca Learn more about PulseMedica at https://www.pulsemedica.com/ Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Zale delves into the world of mental performance with Dr. Cassidy Preston, a renowned mental performance coach. Discover practical mental hacks and habits that can elevate your mindset and performance to enhance your surgical practice. Dr. Preston shares insights on the importance of an inside-out approach, the power of routines, and how to maintain focus and confidence in high-pressure situations. Tune in to learn how to harness your mental game for success in any field. Learn more about Dr. Cassidy Preston at https://drcassidypreston.com/ This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca/ Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Fuchs Dystrophy is an important condition to be aware before operating on any patient.  Cataract surgery, in particular, can cause someone with otherwise asymptomatic Fuchs to develop debilitating corneal edema.  Then again, not everyone with Fuchs Dystrophy is destined to develop corneal swelling.  So how do we determine which patients are at increased risk of corneal decompensation?  How do we know which Fuchs patients warrant combined cataract surgery and endothelial keratoplasty?  And as an alternative to corneal transplantation, how do procedures such as DSO or potentially even endothelial cell injection, factor into our treatment of the condition? Dr. Guillermo Rocha joins the podcast.  Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

With so may IOP-lowering drops on the market, it can be challenging to know which is the most appropriate drop to start a patient on for glaucoma.  How does one choose between the variety of prostaglandin analogs, beta blockers, alpha agonists and carbonic anhydrase inhibitors that are available?  When whould one choose monoterapy vs combination therapies?  How do the drops' side effect profiles influence one's first choice on which drop to start?  Glaucoma specialist Dr. Irfan Kherani joins the podcast. This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca  Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

With the arrival of Eyezirgan (commercial available topical ganciclovir), we now have a more readily accessible preservative-free option for treatment of HSV.  So why is Eyezirgan a potentially important new player on the market?  How does one decide between oral or topical treatments for HSV, and is there a longer-term role for antivirals in the treatment of Zoster, in addition to just HSV? Dr. Parwez Hossain joins the podcast.  This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Giant Cell Arteritis (GCA) is one of the most dreaded diagnoses in ophthalmology; not only can it cause vision loss, but it can also be life threatening.  So what is the threshold for going down the 'GCA diagnostic path'? When should one order an ESR and CRP?  When is the concern high enough to warrant a temporal artery biopsy, and when should steroids be started?  How is temporal artery biopsy changing our diagnostic alogirthm.  Dr. Andrew Lee joins the podcast.  This episode of the podcast is sponsored by Thea Pharma Canada - https://www.theapharma.ca Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.